Parallax Volatility Advisers
LUMO

Parallax Volatility Advisers’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Parallax Volatility Advisers’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-4,467
Closed -$409K – 5115
2017
Q3 		$409K Buy
+4,467
New +$343K ﹤0.01% 1308

Other funds holding LUMO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parallax Volatility Advisers's LUMO Position: Q4 2018 in Review

Parallax Volatility Advisers sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2018, closing a stake of 479 shares — an estimated $10K sold.

Parallax Volatility Advisers first reported a position in LUMO in Q4 2017 and held it in 2 quarters. The position peaked at $36K in Q4 2017. 87 funds tracked by Wall St. Rank hold LUMO as of Q4 2018.

  • Parallax Volatility Advisers reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 479 Lumos Pharma, Inc. Common Stock shares in Q4 2018, an estimated $10K.
  • Parallax Volatility Advisers first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2017 and held it in 2 quarters.
  • Parallax Volatility Advisers's Lumos Pharma, Inc. Common Stock position peaked at $36K in Q4 2017.
  • 87 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2018.

Based on Parallax Volatility Advisers's 13F filing for Q4 2018, filed 14 Feb 2019.